Share class: Bio-Rad Laboratories, Inc.

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A15,065,99089,766 ( 1.772 %) 0 60.28 %
Stock B025,199,88018,154,158 ( 72.04 %) 3,437,382 ( 13.64 %)

Major shareholders: Bio-Rad Laboratories, Inc.

NameStocks%Valuation
Estate Of SCHWARTZ ALICE N
12.51 %
2,714,928 12.51 % 848 M €
First Eagle Investment Management LLC
11.99 %
2,602,772 11.99 % 813 M €
BlackRock Advisors LLC
7.263 %
1,576,112 7.263 % 493 M €
DFA Australia Ltd.
4.927 %
1,069,188 4.927 % 334 M €
Vanguard Capital Management LLC
3.83 %
831,165 3.83 % 260 M €
Vanguard Portfolio Management LLC
3.821 %
829,186 3.821 % 259 M €
Ariel Investments LLC
3.622 %
785,961 3.622 % 246 M €
EARNEST Partners LLC
2.713 %
588,731 2.713 % 184 M €
2.579 %
559,570 2.579 % 175 M €
Capital Research & Management Co. (World Investors)
2.074 %
450,000 2.074 % 141 M €
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
NameStocks%Valuation
Blue Raven Partners LP
80.22 %
4,060,054 80.22 % 1 305 M €
Estate Of SCHWARTZ ALICE N
9.771 %
494,510 9.771 % 159 M €
7.399 %
374,472 7.399 % 120 M €
Parametric Portfolio Associates LLC
5.427 %
274,643 5.427 % 88 M €
UBS Securities LLC
2.082 %
105,389 2.082 % 34 M €
Wells Fargo Clearing Services LLC
1.705 %
86,299 1.705 % 28 M €
0.7556 %
38,240 0.7556 % 12 M €
0.079 %
3,996 0.079 % 1 M €
Flow Traders U.S. LLC
0.0195 %
985 0.0195 % 316 510 €
CSS LLC
0.0193 %
977 0.0193 % 313 939 €
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░
░░░░░░░░░░░░░░░░░░░
░ ░░░ ░░░░% ░░

Breakdown by shareholder type

Institutional82.31%
Others39.87%
Individuals5.9%
State Street Corp.2.58%
SEI Investments Co.1.33%
Manulife Financial Corp.0.46%
ING Groep NV0.41%
Schweizerische Nationalbank0.17%
Governments0.08%
Fifth Third Bancorp0.06%
Regions Financial Corp.0.05%

Based on 1000 largest holdings

Geographical origin of shareholders

United States
109.17%
United Kingdom
6.26%
Individuals
5.9%
Australia
4.93%
Canada
3.63%
Ireland
0.88%
Norway
0.75%
Luxembourg
0.68%
Netherlands
0.42%
Switzerland
0.23%
Germany
0.14%
France
0.04%
Sweden
0.03%
Hong Kong
0.03%
Finland
0.03%
Singapore
0.03%
Austria
0.02%
Puerto Rico
0.02%
Spain
0.01%
Denmark
0.01%
Belgium
0.01%

Based on 1000 largest holdings

Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!